Oana Cristina Seremet

Dr. Oana Cristina Seremet

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2023 in Molecules
Verified
Journal Article
Open access
PDF file
George Mihai NitulescuGeorge Mihai Nitulescu
George Mihai Nitulescu
GSGheorghe Stancov
Gheorghe Stancov
OSOana Cristina Seremet
Oana Cristina Seremet
GNGeorgiana Nitulescu
Georgiana Nitulescu
DMDragos Paul Mihai
Dragos Paul Mihai
OOOctavian Tudorel Olaru
Octavian Tudorel Olaru
The altered activation or overexpression of protein kinases (PKs) is a major subject of research in oncology and their inhibition using small molecules, protein kinases inhibitors (PKI) is the best available option for the cure of cancer. The pyrazole ring is extensively employed in the field of medicinal chemistry and drug development strategies, playing a vital role as a fundamental framework in the structure of various PKIs. This scaffold holds major importance and is considered a privileged structure based on its synthetic accessibility, drug-like properties, and its versatile bioisosteric replacement function. It has proven to play a key role in many PKI, such as the inhibitors of Akt, Aurora kinases, MAPK, B-raf, JAK, Bcr-Abl, c-Met, PDGFR, FGFRT, and RET. Of the 74 small molecule PKI approved by the US FDA, 8 contain a pyrazole ring: Avapritinib, Asciminib, Crizotinib, Encorafenib, Erdafitinib, Pralsetinib, Pirtobrutinib, and Ruxolitinib. The focus of this review is on the importance of the unfused pyrazole ring within the clinically tested PKI and on the additional required elements of their chemical structures. Related important pyrazole fused scaffolds like indazole, pyrrolo[1,2-b]pyrazole, pyrazolo[4,3-b]pyridine, pyrazolo[1,5-a]pyrimidine, or pyrazolo[3,4-d]pyrimidine are beyond the subject of this work.

26 March 2018 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
OSOana Cristina Seremet
Oana Cristina Seremet
OOOctavian Tudorel Olaru
Octavian Tudorel Olaru
CGClaudia Maria Gutu
Claudia Maria Gutu
George Mihai NitulescuGeorge Mihai Nitulescu
George Mihai Nitulescu
MIMihaela Ilie
Mihaela Ilie
Denisa MarginaDenisa Margina
Denisa Margina
Pyrrolizidine alkaloids (PAs) are a widespread class of hepatotoxic heterocyclic organic compounds found in approximately 3% of world flora. Some PAs have been shown to have genotoxic and carcinogenic effects. The present study focuses on the toxicity effects of four dry extracts obtained from medicinal plants (Senecio vernalis, Symphytum officinale, Petasites hybridus and Tussilago farfara), on two aquatic organisms, Artemia salina and Daphnia magna, and the correlation with their PAs content. A new GC‑MS method, using a retention time (TR)‑5MS type capillary column was developed. PAs Kovats retention indices, for this type of column were computed for the first time. The lethal dose 50% (LC50) values for the two invertebrate models were correlated (Pearson 's coefficient, >0.9) and the toxicity was PA concentration-dependent, for three of the four extracts. All tested extracts were found to be toxic in both aquatic organism models. The results can be used to develop a GC‑MS validated method for the assay of PAs in medicinal plants with a further potential application in the risk assessment study of PAs toxicity in humans.

17 December 2023 in Medicina
Verified
Journal Article
Open access
PDF file
PCPușcașu Ciprian
Pușcașu Ciprian
AZAnca Zanfirescu
Anca Zanfirescu
SNSimona Negreș
Simona Negreș
OSOana Cristina Seremet
Oana Cristina Seremet
Phosphodiesterase type 5 (PDE5) is pivotal in cellular signalling, regulating cyclic guanosine monophosphate (cGMP) levels crucial for smooth muscle relaxation and vasodilation. By targeting cGMP for degradation, PDE5 inhibits sustained vasodilation. PDE5 operates in diverse anatomical regions, with its upregulation linked to various pathologies, including cancer and neurodegenerative diseases. Sildenafil, a selective PDE5 inhibitor, is prescribed for erectile dysfunction and pulmonary arterial hypertension. However, considering the extensive roles of PDE5, sildenafil might be useful in other pathologies. This review aims to comprehensively explore sildenafil’s therapeutic potential across medicine, addressing a gap in the current literature. Recognising sildenafil’s broader potential may unveil new treatment avenues, optimising existing approaches and broadening its clinical application.

Verified
Journal Article
Open access
PDF file
DMDragos Paul Mihai
Dragos Paul Mihai
AUAnca Ungurianu
Anca Ungurianu
CCCosmin Ciotu
Cosmin Ciotu
MFMichael J.M. Fischer
Michael J.M. Fischer
OOOctavian Tudorel Olaru
Octavian Tudorel Olaru
SNSimona Negreş
Simona Negreş
Multiple sclerosis (MS) is a demyelinating, autoimmune disease that affects a large number of young adults. Novel therapies for MS are needed considering the efficiency and safety limitations of current treatments. In our study, we investigated the effects of venlafaxine (antidepressant, serotonin-norepinephrine reuptake inhibitor), risperidone (atypical antipsychotic) and febuxostat (gout medication, xanthine oxidase inhibitor) in the cuprizone mouse model of acute demyelination, hypothesizing an antagonistic effect on TRPA1 calcium channels. Cuprizone and drugs were administered to C57BL6/J mice for five weeks and locomotor activity, motor performance and cold sensitivity were assessed. Mice brains were harvested for histological staining and assessment of oxidative stress markers. Febuxostat and metabolites of venlafaxine (desvenlafaxine) and risperidone (paliperidone) were tested for TRPA1 antagonistic activity. Following treatment, venlafaxine and risperidone significantly improved motor performance and sensitivity to a cold stimulus. All administered drugs ameliorated the cuprizone-induced deficit of superoxide dismutase activity. Desvenlafaxine and paliperidone showed no activity on TRPA1, while febuxostat exhibited agonistic activity at high concentrations. Our findings indicated that all three drugs offered some protection against the effects of cuprizone-induced demyelination. The agonistic activity of febuxostat can be of potential use for discovering novel TRPA1 ligands.

11 June 2019 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
DMDragos Paul Mihai
Dragos Paul Mihai
OSOana Cristina Seremet
Oana Cristina Seremet
GNGeorgiana Nitulescu
Georgiana Nitulescu
MIMaria Ivopol
Maria Ivopol
ASAni-Simona Sevastre
Ani-Simona Sevastre
OOOctavian Tudorel Olaru
Octavian Tudorel Olaru
The aim of this work was to assess the analgesic effect of three Vitis vinifera L. leaf extracts and the anti-inflammatory effect of three gels obtained from Aesculus hippocastanum L. seed extracts using animal models, as a preliminary study for the future development of topical preparations based on the combination of extracts with synergistic therapeutic effects on hemorrhoid disease. The analgesic effect was determined by means of the writhing test in mice. The anti-inflammatory effect was determined after administration of carrageenan or kaolin in the rat paw. Extraction using glycerol yielded the highest amounts of flavonoids for both V. vinifera leaves (37.27 ± 1.174 mg/L) and A. hippocastanum seeds (53.48 ± 0.212 mg/L). The highest total phenolic contents were registered for the V. vinifera 20% ethanolic extract (615.3 ± 34.44 mg/L) and for the A. hippocastanum glycerolic extract (247.8 ± 6.991 mg/L). The writhing test revealed that the V. vinifera ethanolic extract induced the most efficient analgesia (57.20%, p < 0.01), better than that induced by the positive control. In the carrageenan inflammation model, only the gel obtained from the A. hippocastanum glycerolic extract significantly reduced paw edema (17.27%, p < 0.05). An anti-inflammatory effect was also observed in the kaolin inflammation model but was not statistically significant (10.12%, p > 0.05). Our findings indicate that V. vinifera and A. hippocastanum extracts may have potential uses for the treatment of pain and inflammation associated with hemorrhoid disease.

30 January 2019 in Chemical Biology & Drug Design
Verified
Journal Article
Open access
PDF file
AUAnca Ungurianu
Anca Ungurianu
OSOana Cristina Seremet
Oana Cristina Seremet
DGDaniela Grădinaru
Daniela Grădinaru
CIConstantin Ionescu‐Tîrgoviște
Constantin Ionescu‐Tîrgoviște
Denisa MarginaDenisa Margina
Denisa Margina
RMRucsandra Dănciulescu Miulescu
Rucsandra Dănciulescu Miulescu
Reactive oxygen species are crucial to normal cell function, but are also part of the pathogenesis of multiple modern maladies. As such, sensitive, fast, and reliable methods of appreciating redox status are needed. We aimed to optimize the Amplex Red (AR) and ferric–xylenol orange (FOX) methods using human serum samples, rat tissue homogenates, and mitochondrial preparations. For AR, we intended to reduce probe concentration, maintaining method sensitivity, as well as extending its use from isolated lipoproteins samples, and readjust it for a high‐throughput application. Also, we evaluated the usefulness of a modified xylenol orange‐based spectrophotometric protocol, comparing and contrasting these methods in terms of clinical relevance and suitability for their further use in assessing redox status of various biological samples in different pathological conditions. Our results show that these optimized protocols are suitable for complex in vivo studies, as they require low quantities of sample and reagents, and are sensitive, rapid, and economical, with the option of adapting them for high‐throughput analysis. For a better assessment of oxidative status of serum‐derived samples, the two methods can be used concurrently, while for tissue‐derived ones, either can be employed for the measurement of a global redox status.